ArticleOncogene2017

Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.

M Burgess et al.PubMed ↗Publisher ↗

No numbers read from the abstract.